ISSN: 2530-0180

Endocrinología, Diabetes y Nutrición is the official publication of the Spanish Society of Endocrinology and Nutrition (SEEN) and the Diabetes Spanish Society (SED) . It is the best journal to keep up to date with endocrine pathophysiology both in the clinical and in the research field. It publishes the best original articles of large research institutions, as well as prestigious reviews.

See more Open Access Option

Indexed in:

Index Medicus/MEDLINE, Excerpta Medica/EMBASE, SCOPUS, Science Citation Index Expanded, Journal Citation Reports/Science Edition, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

1.9

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.474

View more metrics

Journal Information

Special content about coronavirus SARS-CoV-2 (COVID-19) in Endocrinología, Diabetes y Nutrición (English ed.)

Generalizability of results from the recent FDA-guided cardiovascular outcomes trials to a representative population with Type 2 Diabetes attending primary care clinics

Irene Vinagre, Hertzel Gerstein, Clara Viñals, Ignacio Conget

10.1016/j.endien.2019.08.004

Endocrinol Diabetes Nutr. 2019;66:467-8

Open Article

Observational studies with type 2 diabetes mellitus treatments in Spain: A systematic literature review

Silvia Díaz, Tatiana Dilla, Jesus Reviriego

10.1016/j.endien.2019.04.001

Endocrinol Diabetes Nutr 2019;66:254-70

Open Article

Determinants of inertia with lipid-lowering treatment in patients with type 2 diabetes mellitus

Eduardo García Díaz, Davinia Ramírez Medina, Óscar Mauricio Morera Porras, José Luis Cabrera Mateos

10.1016/j.endien.2018.08.008

Endocrinol Diabetes Nutr 2019;66:223-31

Open Article

Obesity and type 2 diabetes: Also linked in therapeutic options

Matilde Rubio-Almanza, Rosa Cámara-Gómez, Juan Francisco Merino-Torres

10.1016/j.endien.2018.11.006

Endocrinol Diabetes Nutr 2019;66:140-9

Open Article

Corticotropin secreting pancreatic neuroendocrine tumour, a therapeutic management challenge. A presentation of 2 cases

Andreu Simó-Servat, Inma Peiró, Carles Villabona

10.1016/j.endien.2018.09.001

Endocrinol Diabetes Nutr 2019;66:204-6

Open Article

Pituitary metastasis of solid tumors: 2 cases of different presentation

Maria Gràcia Cardona-Rovira, Rosa Casañ-Fernández, Javier Sanz-Gallur, Elena Almonacid-Folch, Alba Nadal-Máñez

10.1016/j.endien.2018.11.012

Endocrinol Diabetes Nutr 2019;66:202-3

Open Article

Polymorphism rs3123554 in the cannabinoid receptor type 2 ( CB2R ) gene is associated with metabolic changes after biliopancreatic diversion surgery

Daniel de Luis, Susana Garcia Calvo, David Primo, Olatz Izaola, David Pacheco

10.1016/j.endien.2019.03.002

Endocrinol Diabetes Nutr 2019;66:157-63

Open Article

Prevalence of vascular risk factors in patients with and without type 2 diabetes mellitus admitted to hospital for stroke in the 2011–2013 period

Montserrat González-Pascual, Rafael Barea

10.1016/j.endien.2018.10.011

Endocrinol Diabetes Nutr 2019;66:150-6

Open Article

Haptoglobin levels are influenced by Hp1–Hp2 polymorphism, obesity, inflammation, and hypertension in type 2 diabetes mellitus

Kathryna Fontana Rodrigues, Nathalia Teixeira Pietrani, Laura Machado Lara Carvalho, Adriana Aparecida Bosco, Valéria Cristina Sandrim, Cláudia Natália Ferreira, Karina Braga Gomes

10.1016/j.endien.2019.01.005

Endocrinol Diabetes Nutr 2019;66:99-107

Open Article